U.S. Markets closed
  • S&P 500

    3,298.46
    +51.87 (+1.60%)
     
  • Nasdaq

    10,913.56
    +241.26 (+2.26%)
     
  • Russell 2000

    1,474.91
    +23.09 (+1.59%)
     
  • Crude Oil

    40.04
    -0.27 (-0.67%)
     
  • Gold

    1,864.30
    -12.60 (-0.67%)
     
  • Silver

    22.99
    -0.21 (-0.91%)
     
  • EUR/USD

    1.1637
    -0.0038 (-0.3258%)
     
  • 10-Yr Bond

    0.6590
    -0.0070 (-1.05%)
     
  • Vix

    26.38
    -2.13 (-7.47%)
     
  • GBP/USD

    1.2744
    -0.0007 (-0.0586%)
     
  • BTC-USD

    10,745.36
    +10.00 (+0.09%)
     
  • CMC Crypto 200

    230.19
    +12.36 (+5.67%)
     
  • FTSE 100

    5,842.67
    +19.89 (+0.34%)
     
  • Nikkei 225

    23,204.62
    +116.82 (+0.51%)
     

PRESS DIGEST- Financial Times - Dec 1

Dec 1 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.


Headlines


Bpost sweetens bid in final offer for Dutch rival PostNL

http://on.ft.com/2gzMXTw


Valeant's talks to sell Salix unit for $10 bln break down

http://on.ft.com/2gMqeCP


Blackstone to pursue IPO route for home leasing unit

http://on.ft.com/2gmF8Tn


Overview


Belgian postal company Bpost SA said it made a final offer for Dutch rival PostNL NV, sweetening the cash component of the bid by 0.376 euro to 3.201 euros per share, valuing the bid at about 2.54 billion euros in cash and stock.


Takeda Pharmaceutical Co Ltd's negotiations to acquire Valeant Pharmaceuticals International Inc's Salix stomach-drug business have stalled over price disagreements, people familiar with the matter said on Wednesday.


Invitation Homes LP, the U.S. rental homes manager owned by private equity firm Blackstone Group LP, has confidentially filed for an initial public offering that could come as soon as January and raise as much as $1.5 billion, according to a source familiar with the matter.

(Compiled by Rama Venkat Raman in Bengaluru; Editing by Sandra Maler)